Pellepharm
Menlo Park, US · Founded 2012 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
EE
Ervin EpsteinExecutive Officer, Director
JT
Jean TangDirector
MD
Mark de SouzaExecutive Officer
KA
Katrin AndreassonDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$7.5MraisedJul 2018 · 7 investors · BiotechnologyRule 506(b)
▶$7.5MraisedJul 2018 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sanuj Ravinddran, M.D.Executive Officer, Director, Promoter
- Neil Kumar, Ph.D.Director
- Frank McCormick, Ph.D.Director
- Ervin Epstein, M.D.Director
- Jean Y. Tang, M.D., Ph.D.Director
- Offering amount
- $7.5M
- Amount sold
- $7.5M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.2MraisedAug 2016 · 4 investors · BiotechnologyRule 506(b)
▶$3.2MraisedAug 2016 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Neil Kumar, PH.D.Director
- Mark De Souza, Ph.D.Executive Officer, Director
- Frank McCormick, Ph.D.Director
- Ervin Epstein, M.D.Executive Officer, Director
- Jean Tang, M.D., Ph.D.Director
- Offering amount
- $7.5M
- Amount sold
- $3.2M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$719.7KraisedOct 2015 · 1 investors · BiotechnologyRule 506(b)
▶$719.7KraisedOct 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank McCormickDirector
- Ervin EpsteinExecutive Officer, Director
- Mark De SouzaExecutive Officer, Director
- Neil KumarDirector
- Jean TangDirector
- Offering amount
- $719.7K
- Amount sold
- $719.7K
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$4.5MraisedJul 2015 · 1 investors · BiotechnologyRule 506(b)
▶$4.5MraisedJul 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Katrin AndreassonDirector
- Ervin EpsteinExecutive Officer, Director
- Jean TangDirector
- Mark de SouzaExecutive Officer
- Offering amount
- $4.5M
- Amount sold
- $4.5M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$118.6KraisedMay 2015 · 1 investors · BiotechnologyRule 506(b)
▶$118.6KraisedMay 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ervin EpsteinExecutive Officer, Director
- Jean TangDirector
- Katrin AndreassonDirector
- Mark de SouzaExecutive Officer
- Offering amount
- $118.6K
- Amount sold
- $118.6K
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$1.8MraisedApr 2015 · 8 investors · BiotechnologyRule 506(b)
▶$1.8MraisedApr 2015 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ervin EpsteinExecutive Officer, Director
- Jean TangDirector
- Mark de SouzaExecutive Officer
- Katrin AndreassonDirector
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.